Recombinant ferrochelatase (hemH) refers to the genetically engineered form of the enzyme ferrochelatase, encoded by the hemH gene, which catalyzes the final step in heme biosynthesis: the insertion of ferrous iron (Fe²⁺) into protoporphyrin IX to form protoheme . This metalloenzyme is critical across eukaryotes and prokaryotes, with variations in substrate specificity and localization. In Gram-positive bacteria like Bacillus subtilis, hemH homologs (e.g., CpfC) catalyze iron insertion into coproporphyrin III , while eukaryotic ferrochelatases predominantly act on protoporphyrin IX in mitochondria . Recombinant production enables large-scale studies and biotechnological applications, such as optimizing heme synthesis in microbial systems .
Core structure: Composed of two Rossmann-fold domains forming the active site, conserved across species .
CAB domain: Present in cyanobacterial and plant type II ferrochelatases (e.g., Synechocystis sp. PCC 6803), this C-terminal chlorophyll a/b-binding domain regulates enzyme activity and substrate flux .
Metal-sensitive loop: A flexible loop (residues Q302–Q314 in humans) modulates substrate entry and product release .
Full-length FeCh: K<sub>M</sub> = 12.5 µM (protoporphyrin IX), k<sub>cat</sub> = 1.2 min⁻¹ .
FeChΔ347: K<sub>M</sub> = 18.9 µM, k<sub>cat</sub> = 3.6 min⁻¹ .
Human ferrochelatase: Inhibited by nitric oxide and redox modifications (e.g., glutathionylation) .
Substrate competition: CAB domain in cyanobacterial ferrochelatase directs porphyrin flux toward chlorophyll synthesis, reducing heme output .
Transcriptional control: In E. coli, hemH overexpression represses upstream heme pathway genes (e.g., hemA, hemL), reducing δ-aminolevulinic acid (ALA) accumulation .
Co-expression of recombinant ferrochelatase with heme-binding proteins (e.g., nitric oxide synthase) ensures complete heme incorporation, critical for structural and commercial applications .
| Application | Strategy | Outcome |
|---|---|---|
| ALA overproduction | Overexpress hemA, hemL, hemD | 3.25 g/L ALA in E. coli |
| Heme protein purity | Co-express hemH with target | 100% heme incorporation |
Ferrochelatase variants lacking regulatory domains (e.g., CAB) enhance heme yields in photosynthetic microbes .
Redox-sensitive residues (e.g., C395 in humans) are targets for optimizing activity under industrial conditions .
Mechanistic details: The role of the [2Fe-2S] cluster in eukaryotic ferrochelatase redox sensing remains unclear .
Chaperone interactions: Heme trafficking partners post-release from ferrochelatase are unidentified .
CAB domain ligands: Pigment binding to the CAB domain hypothesized to regulate chlorophyll/heme balance requires direct evidence .
KEGG: ecv:APECO1_1540